T
Tilray Inc (TLRY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
$2.34
-0.09 (-3.70%)
Market Cap: $359.12M
Last updated: Nov 17, 2026 at 11:06 AM ET
Tilray Inc (TLRY) Valuation Multiples
Tilray (TLRY) trades at 0.3x sales and 0.2x book value. Its forward P/E is 1000.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 1000.0x |
| Price to sales | 0.3x |
| Price to book | 0.2x |
| PEG | N/A |
| FCF yield | -38.1% |
Valuation History
Over the 3 of the 8 year ends shown that have a P/B, its P/B ranged from 0.3x in 2022 to 0.7x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $9.03 | N/A | N/A |
| 2024 | $13.30 | N/A | N/A |
| 2023 | $23.00 | N/A | 0.5x |
| 2022 | $26.90 | 2.4x | 0.3x |
| 2021 | $70.30 | N/A | 0.7x |
| 2020 | $82.60 | N/A | N/A |
| 2019 | $171.30 | N/A | N/A |
| 2018 | $705.40 | N/A | N/A |
Frequently Asked Questions About TLRY
What is TLRY's forward P/E ratio?
Tilray has a forward P/E ratio of 1000.0x.
What is TLRY's price to sales ratio?
Tilray has a price to sales ratio of 0.3x.
TLRY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors